Loading...
Loading...
CPIX| Name | Value |
|---|---|
| Revenues | 10.1M |
| Cost of Revenue | 1.8M |
| Gross Profit | 8.3M |
| Operating Expense | 10.2M |
| Operating I/L | -1.9M |
| Other Income/Expense | 0.8M |
| Interest Income | 0.1M |
| Pretax | -1.1M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -1.0M |
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that focuses on acquiring, developing, and commercializing prescription products for hospital acute care, gastroenterology, rheumatology, and oncology. The company's product portfolio includes Acetadote for acetaminophen poisoning, Caldolor for pain and fever, Kristalose for constipation, Omeclamox-Pak for Helicobacter pylori infection, Vaprisol for hyponatremia, Vibativ for bacterial infections, and RediTrex for rheumatoid arthritis and psoriasis. Additionally, Cumberland is developing ifetroban for various conditions and a cholesterol-reducing agent for hospital use.
